Acquired cisplatin resistance human ovarian cancer cells enhanced repair cisplatin-DNA lesions reduced drug accumulation Studies resistance human ovarian cancer cells cell lines respective characteristics drug accumulation efflux cytosolic inactivation drug DNA repair experiments drug exposures cell line resistant cells respective doses drug accumulation rates similar cell lines resistant cell line efficient drug reduced total drug accumulation equivalent micromolar drug exposures equivalent levels total cellular drug accumulation cell lines levels cisplatin-DNA damage cytosolic inactivation drug differential resistance cell lines Resistant cells efficient cisplatin-DNA lesions cellular DNA transfected plasmid DNA cell lines alterations drug uptake/efflux DNA repair major factors resistance 